Back to Search
Start Over
Hot Picks for 2022.
- Source :
- Pharmaceutical Technology Europe; Jan2022, Vol. 34 Issue 1, p6-6, 1/2p
- Publication Year :
- 2022
-
Abstract
- The author highlights the late-stage treatments that are expected to earn one billion dollars in the next five years according to Clarivate in 2022 including adagrasib from Mirati Therapeutics and Zai Lab, faricimab from Roche and Chugai Pharmaceutical, and vutrisiran from Alnylam Pharmaceuticals.
Details
- Language :
- English
- ISSN :
- 17537967
- Volume :
- 34
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Pharmaceutical Technology Europe
- Publication Type :
- Periodical
- Accession number :
- 154809940